◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

JBM (Healthcare) Limited (2161) Financial History

Name: JBM (Healthcare) Limited (2161) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

JBM (Healthcare) Limited (2161) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kwun Tong, Hong Kong with about 404 employees. Its market capitalization is roughly HKD 2 billion. In the fiscal year ended 2026-03-31, 2161 reported HKD 835M in revenue and HKD 201M in net income.

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.

Interactive charts & full statements →

2161 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	HKD 835M	HKD 782M	HKD 648M	HKD 520M	—
Gross Profit	HKD 466M	HKD 414M	HKD 338M	HKD 206M	—
Operating Income (EBIT)	HKD 255M	HKD 229M	HKD 158M	HKD 73M	—
Net Income	HKD 201M	HKD 197M	HKD 130M	HKD 57M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2161 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(HKD 174M)	(HKD 79M)	(HKD 53M)	(HKD 4M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2161 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	HKD 1.8B	HKD 1.5B	HKD 1.4B	HKD 1.4B	—
Total Liabilities	HKD 632M	HKD 381M	HKD 367M	HKD 372M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2161 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

PRGO · Perrigo Company plc — $2 billion
ANIP · ANI Pharmaceuticals, Inc. — $2 billion
TRLV · Trulieve Cannabis Corp. — $2 billion
ETON · Eton Pharmaceuticals, Inc. — $2 billion
HROW · Harrow, Inc. — $2 billion
2348 · Dawnrays Pharmaceutical (Holdings) Limited — $1 billion
PPGN · PolyPeptide Group AG — $1 billion
1061 · Essex Bio-Technology Limited — $1 billion

← 2160 All “0-9” companies 2162 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.